|
GS185131: GO:0044699 single-organism process
|
|
GS207306: GO:0080134 regulation of response to stress
|
|
GS198398: GO:0050670 regulation of lymphocyte proliferation
|
|
GS191217: GO:0045087 innate immune response
|
|
GS198248: GO:0045063 T-helper 1 cell differentiation
|
|
GS206023: GO:0045622 regulation of T-helper cell differentiation
|
|
GS169127: MP:0002445 abnormal mononuclear cell differentiation
|
|
GS136784: seizure severity 2 (Szv2, Published QTL Chr 7)
|
|
GS168559: MP:0002421 abnormal cell-mediated immunity
|
|
GS169830: MP:0005384 cellular phenotype
|
|
GS136339: nicotine induced locomotor activity 4 (Nilac4, Published QTL Chr 7)
|
|
GS136306: myocardial infarction 1 (Myci1, Published QTL Chr 7)
|
|
GS165858: MP:0005000 abnormal immune tolerance
|
|
GS207674: GO:0002697 regulation of immune effector process
|
|
GS206098: GO:0002263 cell activation involved in immune response
|
|
GS166037: MP:0005350 increased susceptibility to autoimmune disorder
|
|
GS168334: MP:0002619 abnormal lymphocyte morphology
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS180879: GO:0051247 positive regulation of protein metabolic process
|
|
GS191035: GO:0005125 cytokine activity
|
|
GS188012: GO:0002825 regulation of T-helper 1 type immune response
|
|
GS203972: GO:0005615 extracellular space
|
|
GS166858: MP:0000685 abnormal immune system morphology
|
|
GS192540: GO:0045580 regulation of T cell differentiation
|
|
GS184917: GO:0002252 immune effector process
|
|
GS177265: GO:0048731 system development
|
|
GS193238: GO:0031323 regulation of cellular metabolic process
|
|
GS121937: Luteolin interacting genes (MeSH:D047311) in CTD
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS188142: GO:0048856 anatomical structure development
|
|
GS177205: GO:0042095 interferon-gamma biosynthetic process
|
|
GS197947: GO:0002287 alpha-beta T cell activation involved in immune response
|
|
GS196988: GO:0045595 regulation of cell differentiation
|
|
GS202162: GO:0005126 cytokine receptor binding
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS204870: GO:0002825 regulation of T-helper 1 type immune response
|
|
GS202338: GO:0002294 CD4-positive, alpha-beta T cell differentiation involved in immune response
|
|
GS35026: Neocortex Gene expression correlates of Percentage of time into open arms of plus maze in Females & Males BXD
|
|
GS169772: MP:0001844 autoimmune response
|
|
GS84196: alcohol preference locus (Published QTL, Chr 7)
|
|
GS194715: GO:0046631 alpha-beta T cell activation
|
|
GS35365: Neocortex Gene expression correlates of Amount of time in open arms of plus maze in Females & Males BXD
|
|
GS194455: GO:0051239 regulation of multicellular organismal process
|
|
GS127931: Olfactory bulb - Allen Mouse Brain Atlas
|
|
GS208131: GO:0045087 innate immune response
|
|
GS165414: MP:0002498 abnormal acute inflammation
|
|
GS178426: GO:0005102 receptor binding
|
|
GS180852: GO:0006954 inflammatory response
|
|
GS205237: GO:0030217 T cell differentiation
|
|
GS201367: GO:0019538 protein metabolic process
|
|
GS208716: GO:2000026 regulation of multicellular organismal development
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS193154: GO:0032944 regulation of mononuclear cell proliferation
|
|
GS84199: METH responses for body temperature (Published QTL, Chr 7)
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS135272: "alcohol preference locus 12, male specific" (Alcp12, Published QTL Chr 7)
|
|
GS210178: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS135542: cerebellar cAMP 5 (Ccmp5, Published QTL Chr 7)
|
|
GS127934: Retrohippocampal region - Allen Mouse Brain Atlas
|
|
GS197669: GO:0051246 regulation of protein metabolic process
|
|
GS136924: VPA induced neural tube defect (Vpantd, Published QTL Chr 7)
|
|
GS185489: GO:0046651 lymphocyte proliferation
|
|
GS204150: GO:0009611 response to wounding
|
|
GS206329: GO:0060255 regulation of macromolecule metabolic process
|
|
GS136762: soft tissue heal 6 (Stheal6, Published QTL Chr 7)
|
|
GS136937: vertebral trabecular bone trait 4 (Vtbt4, Published QTL Chr 7)
|
|
GS193234: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS197666: GO:0051249 regulation of lymphocyte activation
|
|
GS204871: GO:0002822 regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
|
GS168987: MP:0005088 increased acute inflammation
|
|
GS177123: GO:0045072 regulation of interferon-gamma biosynthetic process
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS204130: GO:0009615 response to virus
|
|
GS169774: MP:0001846 increased inflammatory response
|
|
GS181608: GO:0050670 regulation of lymphocyte proliferation
|
|
GS202313: GO:0046651 lymphocyte proliferation
|
|
GS209951: GO:0042127 regulation of cell proliferation
|
|
GS177970: GO:0046632 alpha-beta T cell differentiation
|
|
GS135817: ethanol induced thermoregulation 3 (Ethm3, Published QTL Chr 7)
|
|
GS181980: GO:2000514 regulation of CD4-positive, alpha-beta T cell activation
|
|
GS204478: GO:0070661 leukocyte proliferation
|
|
GS187175: GO:0045321 leukocyte activation
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS181473: GO:0005488 binding
|
|
GS167714: MP:0002414 abnormal myeloblast morphology/development
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS197694: GO:0002460 adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
|
GS191150: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS187615: GO:0070661 leukocyte proliferation
|
|
GS210170: GO:0030097 hemopoiesis
|
|
GS135577: cystic fibrosis lung disease 4 (Cfld4, Published QTL Chr 7)
|
|
GS167315: MP:0002148 abnormal hypersensitivity reaction
|
|
GS193227: GO:0030097 hemopoiesis
|
|
GS84195: nicotine sensitivity (Published QTL, Chr 7)
|
|
GS191779: GO:2000026 regulation of multicellular organismal development
|
|
GS167542: MP:0001790 abnormal immune system physiology
|
|
GS167326: MP:0002145 abnormal T cell differentiation
|
|
GS204746: GO:0080090 regulation of primary metabolic process
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS177207: GO:0042098 T cell proliferation
|
|
GS193991: GO:0048731 system development
|
|
GS163779: MP:0004799 increased susceptibility to experimental autoimmune encephalomyelitis
|
|
GS127929: Medulla - Allen Mouse Brain Atlas
|
|
GS198773: GO:2000514 regulation of CD4-positive, alpha-beta T cell activation
|
|
GS184451: GO:0044421 extracellular region part
|
|
GS185340: GO:0005126 cytokine receptor binding
|
|
GS135440: bone mineral density 9 (Bmd9, Published QTL Chr 7)
|
|
GS136732: susceptibility to lung cancer 8 (Sluc8, Published QTL Chr 7)
|
|
GS193270: GO:0005576 extracellular region
|
|
GS194709: GO:0046637 regulation of alpha-beta T cell differentiation
|
|
GS199584: GO:0045523 interleukin-27 receptor binding
|
|
GS127938: Striatum - Allen Mouse Brain Atlas
|
|
GS189158: GO:0045625 regulation of T-helper 1 cell differentiation
|
|
GS169767: MP:0002396 abnormal hematopoietic system morphology/development
|
|
GS193236: GO:0031326 regulation of cellular biosynthetic process
|
|
GS207673: GO:0002694 regulation of leukocyte activation
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS169777: MP:0002398 abnormal bone marrow cell morphology/development
|
|
GS181458: GO:0045063 T-helper 1 cell differentiation
|
|
GS136663: skin tumor susceptibility 2 (Skts2, Published QTL Chr 7)
|
|
GS203335: GO:0048513 organ development
|
|
GS180556: GO:0050776 regulation of immune response
|
|
GS193225: GO:0030098 lymphocyte differentiation
|
|
GS166250: MP:0008247 abnormal mononuclear cell morphology
|
|
GS182223: GO:0002366 leukocyte activation involved in immune response
|
|
GS187113: GO:0005615 extracellular space
|
|
GS210212: GO:0005575 cellular_component
|
|
GS193929: GO:0042098 T cell proliferation
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS196443: GO:0043370 regulation of CD4-positive, alpha-beta T cell differentiation
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS188762: GO:0009889 regulation of biosynthetic process
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS196293: GO:0035710 CD4-positive, alpha-beta T cell activation
|
|
GS197924: GO:0046649 lymphocyte activation
|
|
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS135999: hepatic lipase activity in BSB 1 (Hlbsb1, Published QTL Chr 7)
|
|
GS189579: GO:0042088 T-helper 1 type immune response
|
|
GS168422: MP:0000716 abnormal immune system cell morphology
|
|
GS177492: GO:0045078 positive regulation of interferon-gamma biosynthetic process
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS136272: multigenic obesity QTL 1 (Mobq1, Published QTL Chr 7)
|
|
GS193479: GO:0045619 regulation of lymphocyte differentiation
|
|
GS193150: GO:0032943 mononuclear cell proliferation
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS193839: GO:0045072 regulation of interferon-gamma biosynthetic process
|
|
GS188013: GO:0002822 regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
|
GS203491: GO:0051707 response to other organism
|
|
GS84197: alcohol preference locus 14, female specific (Alcp14, Published QTL, Chr 7)
|
|
GS200016: GO:0001817 regulation of cytokine production
|
|
GS169535: MP:0005397 hematopoietic system phenotype
|
|
GS210180: GO:0031326 regulation of cellular biosynthetic process
|
|
GS206291: GO:0032609 interferon-gamma production
|
|
GS135492: behavioral response to methamphetamines 6 (Brmth6, Published QTL Chr 7)
|
|
GS205622: GO:0009889 regulation of biosynthetic process
|
|
GS191151: GO:0010556 regulation of macromolecule biosynthetic process
|
|
GS169773: MP:0001845 abnormal inflammatory response
|
|
GS189460: GO:0060255 regulation of macromolecule metabolic process
|
|
GS136716: susceptibility to lung cancer 19 (Sluc19, Published QTL Chr 7)
|
|
GS84198: METH responses for home cage activity (Published QTL, Chr 7)
|
|
GS195206: GO:0002520 immune system development
|
|
GS135854: femoral bone morphometry 3 (Fembm3, Published QTL Chr 7)
|
|
GS194226: GO:0045078 positive regulation of interferon-gamma biosynthetic process
|
|
GS127935: Striatum dorsal region - Allen Mouse Brain Atlas
|
|
GS206450: GO:0042088 T-helper 1 type immune response
|
|
GS208061: GO:0010556 regulation of macromolecule biosynthetic process
|
|
GS196943: GO:0008152 metabolic process
|
|
GS206451: GO:0042089 cytokine biosynthetic process
|
|
GS177971: GO:0046631 alpha-beta T cell activation
|
|
GS185510: GO:0002293 alpha-beta T cell differentiation involved in immune response
|
|
GS190770: GO:0002694 regulation of leukocyte activation
|
|
GS196941: GO:0008150 biological_process
|
|
GS207176: GO:0050865 regulation of cell activation
|
|
GS206024: GO:0045625 regulation of T-helper 1 cell differentiation
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS190893: GO:0030154 cell differentiation
|
|
GS201186: GO:0042108 positive regulation of cytokine biosynthetic process
|
|
GS136596: resistance to thymic deletion 1 (Rthyd1, Published QTL Chr 7)
|
|
GS210182: GO:0031323 regulation of cellular metabolic process
|
|
GS201431: GO:0005515 protein binding
|
|
GS208107: GO:0009607 response to biotic stimulus
|
|
GS136261: "murine leukemia virus infection QTL, 1" (Mlviq1, Published QTL Chr 7)
|
|
GS165615: MP:0002123 abnormal hematopoiesis
|
|
GS206192: GO:0048583 regulation of response to stimulus
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS190027: GO:0006952 defense response
|
|
GS209277: GO:0002831 regulation of response to biotic stimulus
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS177548: GO:0048534 hematopoietic or lymphoid organ development
|
|
GS128573: Ethanol Induced Hypothermia Chr# 7
|
|
GS163314: MP:0005005 abnormal self tolerance
|
|
GS190682: GO:0007275 multicellular organismal development
|
|
GS136843: thymic lymphoma susceptible 1 (Tlsm1, Published QTL Chr 7)
|
|
GS168551: MP:0002429 abnormal blood cell morphology/development
|
|
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS210181: GO:0031325 positive regulation of cellular metabolic process
|
|
GS168560: MP:0002420 abnormal adaptive immunity
|
|
GS208051: GO:0002521 leukocyte differentiation
|
|
GS185511: GO:0002292 T cell differentiation involved in immune response
|
|
GS201255: GO:0044421 extracellular region part
|
|
GS192003: GO:0043367 CD4-positive, alpha-beta T cell differentiation
|
|
GS180208: GO:0045595 regulation of cell differentiation
|
|
GS169827: MP:0005387 immune system phenotype
|
|
GS136153: limb length QTL 3 (Lmblgq3, Published QTL Chr 7)
|
|
GS177200: GO:0042093 T-helper cell differentiation
|
|
GS204568: GO:0009893 positive regulation of metabolic process
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS184629: GO:0005515 protein binding
|
|
GS136671: skull morphology 10 (Skull10, Published QTL Chr 7)
|
|
GS135273: "alcohol preference locus 14, female specific" (Alcp14, Published QTL Chr 7)
|
|
GS177843: GO:0002376 immune system process
|
|
GS192539: GO:0006955 immune response
|
|
GS135720: determination of interleukin 4 commitment 2 (Dice2, Published QTL Chr 7)
|
|
GS180152: GO:0065007 biological regulation
|
|
GS186488: GO:0048513 organ development
|
|
GS170601: MP:0005621 abnormal cell physiology
|
|
GS187293: GO:0009611 response to wounding
|
|
GS194284: GO:0048534 hematopoietic or lymphoid organ development
|
|
GS189326: GO:0048583 regulation of response to stimulus
|
|
GS196806: GO:0032502 developmental process
|
|
GS206618: GO:0050793 regulation of developmental process
|
|
GS170301: MP:0005617 increased susceptibility to type IV hypersensitivity reaction
|
|
GS168273: MP:0002432 abnormal CD4-positive T cell morphology
|
|
GS208664: GO:0008283 cell proliferation
|
|
GS210214: GO:0005576 extracellular region
|
|
GS200432: GO:0002682 regulation of immune system process
|
|
GS201592: GO:0009617 response to bacterium
|
|
GS195855: GO:0050688 regulation of defense response to virus
|
|
GS193011: GO:0042129 regulation of T cell proliferation
|
|
GS164022: MP:0008246 abnormal leukocyte morphology
|
|
GS194586: GO:0002376 immune system process
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS190949: GO:0009058 biosynthetic process
|
|
GS128593: Average rotarod training latency Chr# 7
|
|
GS135758: experimental allergic encephalomyelitis susceptibility 26 (Eae26, Published QTL Chr 7)
|
|
GS197644: GO:0006954 inflammatory response
|
|
GS204036: GO:0045321 leukocyte activation
|
|
GS183217: GO:0001817 regulation of cytokine production
|
|
GS197946: GO:0002286 T cell activation involved in immune response
|
|
GS201265: GO:0009891 positive regulation of biosynthetic process
|
|
GS179684: GO:0043370 regulation of CD4-positive, alpha-beta T cell differentiation
|
|
GS170414: MP:0008076 abnormal CD4-positive T cell differentiation
|
|
GS184915: GO:0002250 adaptive immune response
|
|
GS189231: GO:0002263 cell activation involved in immune response
|
|
GS135632: collagen induced arthritis 42 (Cia42, Published QTL Chr 7)
|
|
GS127924: Cerebral cortex - Allen Mouse Brain Atlas
|
|
GS136763: soft tissue heal 7 (Stheal7, Published QTL Chr 7)
|
|
GS127925: Hippocampal formation - Allen Mouse Brain Atlas
|
|
GS194605: GO:0001775 cell activation
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS189157: GO:0045622 regulation of T-helper cell differentiation
|
|
GS184461: GO:0009891 positive regulation of biosynthetic process
|
|
GS180903: GO:0002460 adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
|
GS177356: GO:0003674 molecular_function
|
|
GS207940: GO:0005125 cytokine activity
|
|
GS177717: GO:0051239 regulation of multicellular organismal process
|
|
GS177965: GO:0046637 regulation of alpha-beta T cell differentiation
|
|
GS180875: GO:0051249 regulation of lymphocyte activation
|
|
GS190286: GO:0050863 regulation of T cell activation
|
|
GS196837: GO:0042110 T cell activation
|
|
GS192471: GO:0048869 cellular developmental process
|
|
GS180166: GO:0008152 metabolic process
|
|
GS191727: GO:0008283 cell proliferation
|
|
GS200219: GO:0043900 regulation of multi-organism process
|
|
GS210095: GO:0032943 mononuclear cell proliferation
|
|
GS189939: GO:0032649 regulation of interferon-gamma production
|
|
GS180063: GO:0042110 T cell activation
|
|
GS189580: GO:0042089 cytokine biosynthetic process
|
|
GS202335: GO:0002293 alpha-beta T cell differentiation involved in immune response
|
|
GS127937: Striatum-like amygdalar nuclei - Allen Mouse Brain Atlas
|
|
GS184382: GO:0042107 cytokine metabolic process
|
|
GS206909: GO:0006952 defense response
|
|
GS190771: GO:0002697 regulation of immune effector process
|
|
GS209481: GO:0045580 regulation of T cell differentiation
|
|
GS127936: Striatum ventral region - Allen Mouse Brain Atlas
|
|
GS136748: susceptibility to sialadenitis 3 (Ssial3, Published QTL Chr 7)
|
|
GS181159: GO:0002285 lymphocyte activation involved in immune response
|
|
GS187751: GO:0019222 regulation of metabolic process
|
|
GS136142: lithogenic gene 22 (Lith22, Published QTL Chr 7)
|
|
GS191144: GO:0002521 leukocyte differentiation
|
|
GS209480: GO:0006955 immune response
|
|
GS193237: GO:0031325 positive regulation of cellular metabolic process
|
|
GS124299: Poly I-C interacting genes (MeSH:D011070) in CTD
|
|
GS195214: GO:0009987 cellular process
|
|
GS179528: GO:0035710 CD4-positive, alpha-beta T cell activation
|
|
GS180034: GO:0032502 developmental process
|
|
GS203318: GO:0042035 regulation of cytokine biosynthetic process
|
|
GS190280: GO:0050865 regulation of cell activation
|
|
GS188381: GO:0030217 T cell differentiation
|
|
GS181133: GO:0046649 lymphocyte activation
|
|
GS136609: colon tumor susceptibility 12 (Scc12, Published QTL Chr 7)
|
|
GS198263: GO:0005488 binding
|
|
GS193009: GO:0042127 regulation of cell proliferation
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS194712: GO:0046634 regulation of alpha-beta T cell activation
|
|
GS210424: GO:0045619 regulation of lymphocyte differentiation
|
|
GS182786: GO:0045523 interleukin-27 receptor binding
|
|
GS189423: GO:0032609 interferon-gamma production
|
|
GS197948: GO:0002285 lymphocyte activation involved in immune response
|
|
GS206820: GO:0032649 regulation of interferon-gamma production
|
|
GS135571: cystic fibrosis body weight 3 (Cfbw3, Published QTL Chr 7)
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS183630: GO:0002682 regulation of immune system process
|
|
GS127939: Thalamus - Allen Mouse Brain Atlas
|
|
GS178453: GO:0002520 immune system development
|
|
GS168270: MP:0002435 abnormal effector T cell morphology
|
|
GS125069: Sodium Selenite interacting genes (MeSH:D018038) in CTD
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS136368: obesity QTL 15 (Obq15, Published QTL Chr 7)
|
|
GS180164: GO:0008150 biological_process
|
|
GS194714: GO:0046632 alpha-beta T cell differentiation
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS189746: GO:0050793 regulation of developmental process
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS135985: hematocrit QTL 3 (Hemq3, Published QTL Chr 7)
|
|
GS129150: IL-4 producing potential QTL (Il4ppq Published QTL Chr 7)
|
|
GS207858: GO:0009059 macromolecule biosynthetic process
|
|
GS127933: Pons - Allen Mouse Brain Atlas
|
|
GS163560: MP:0008037 abnormal T cell morphology
|
|
GS195176: GO:0005102 receptor binding
|
|
GS197670: GO:0051247 positive regulation of protein metabolic process
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS209993: GO:0051607 defense response to virus
|
|
GS209953: GO:0042129 regulation of T cell proliferation
|
|
GS177968: GO:0046634 regulation of alpha-beta T cell activation
|
|
GS193563: GO:0006950 response to stress
|
|
GS187616: GO:0070663 regulation of leukocyte proliferation
|
|
GS135979: wound healing/regeneration 6 (Heal6, Published QTL Chr 7)
|
|
GS180878: GO:0051246 regulation of protein metabolic process
|
|
GS124648: Lipopolysaccharides interacting genes (MeSH:D008070) in CTD
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS201949: GO:0044699 single-organism process
|
|
GS187960: GO:0002819 regulation of adaptive immune response
|
|
GS200015: GO:0001816 cytokine production
|
|
GS190950: GO:0009059 macromolecule biosynthetic process
|
|
GS199020: GO:0002366 leukocyte activation involved in immune response
|
|
GS181158: GO:0002287 alpha-beta T cell activation involved in immune response
|
|
GS178461: GO:0009987 cellular process
|
|
GS207182: GO:0050863 regulation of T cell activation
|
|
GS210507: GO:0006950 response to stress
|
|
GS201728: GO:0002250 adaptive immune response
|
|
GS193268: GO:0005575 cellular_component
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS193922: GO:0042093 T-helper cell differentiation
|
|
GS164113: MP:0002534 abnormal type IV hypersensitivity reaction
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS208942: GO:0043367 CD4-positive, alpha-beta T cell differentiation
|
|
GS136460: postnatal body weight growth 3 (Pbwg3, Published QTL Chr 7)
|
|
GS201730: GO:0002252 immune effector process
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS184379: GO:0042108 positive regulation of cytokine biosynthetic process
|
|
GS201189: GO:0042107 cytokine metabolic process
|
|
GS167991: MP:0002401 abnormal lymphopoiesis
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS210168: GO:0030098 lymphocyte differentiation
|
|
GS186471: GO:0042035 regulation of cytokine biosynthetic process
|
|
GS177862: GO:0001775 cell activation
|
|
GS204819: GO:0002819 regulation of adaptive immune response
|
|
GS200844: GO:0031347 regulation of defense response
|
|
GS135942: HDL cholesterol level 1 (Hdlcl1, Published QTL Chr 7)
|
|
GS164133: MP:0005076 abnormal cell differentiation
|
|
GS185513: GO:0002294 CD4-positive, alpha-beta T cell differentiation involved in immune response
|
|
GS210099: GO:0032944 regulation of mononuclear cell proliferation
|
|
GS168563: MP:0002425 altered susceptibility to autoimmune disorder
|
|
GS203494: GO:0051704 multi-organism process
|
|
GS135396: body growth early QTL 6 (Bgeq6, Published QTL Chr 7)
|
|
GS183216: GO:0001816 cytokine production
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS202336: GO:0002292 T cell differentiation involved in immune response
|
|
GS187708: GO:0009893 positive regulation of metabolic process
|
|
GS197349: GO:0050776 regulation of immune response
|
|
GS136899: ventral midbrain iron content 3 (Vmbic3, Published QTL Chr 7)
|
|
GS181157: GO:0002286 T cell activation involved in immune response
|
|
GS204479: GO:0070663 regulation of leukocyte proliferation
|
|
GS193927: GO:0042095 interferon-gamma biosynthetic process
|
|
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS127926: Hippocampal region - Allen Mouse Brain Atlas
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS127932: Pallidum - Allen Mouse Brain Atlas
|
|
GS167627: MP:0005460 abnormal leukopoiesis
|